The Valley Desk

NCT00041041 · Interventional trial

Imatinib Mesylate in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal Cancer

Overall registry status Completed

Phase 2

Conditions Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov